(Q34658787)

English

Comparison of two commercial vaccines against visceral leishmaniasis in dogs from endemic areas: IgG, and subclasses, parasitism, and parasite transmission by xenodiagnosis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Comparison of two commercial vaccines against visceral leishmaniasis in dogs from endemic areas: IgG, and subclasses, parasitism, and parasite transmission by xenodiagnosis (English)

1 reference

Europe PubMed Central

3 August 2017

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

Stella Maria Barrouin-Melo

object named as

Stella Maria Barrouin-Melo

8

0 references

Patrícia Sampaio Tavares Veras

object named as

Patricia Sampaio Tavares Veras

7

1 reference

https://orcid.org/0000-0001-8308-9263

author name string

Consuelo Barreto Fernandes

1

1 reference

Europe PubMed Central

3 August 2017

Jairo Torres Magalhães Junior

2

1 reference

Europe PubMed Central

3 August 2017

Clauceane de Jesus

3

1 reference

Europe PubMed Central

3 August 2017

Bárbara Maria Paraná da Silva Souza

4

1 reference

Europe PubMed Central

3 August 2017

Daniela Farias Larangeira

5

1 reference

Europe PubMed Central

3 August 2017

Deborah Bittencourt Mothé Fraga

6

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

6 January 2014

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

32

1 reference

Europe PubMed Central

3 August 2017

11

1 reference

Europe PubMed Central

3 August 2017

1287-1295

1 reference

Europe PubMed Central

3 August 2017

Comparative microsatellite typing of new world leishmania infantum reveals low heterogeneity among populations and its recent old world origin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Visceral leishmaniasis in Brazil: trends and challenges

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Infectiousness in a cohort of brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Canine leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S�o Gon�alo do Amarante, RN)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Safety trial using the Leishmune vaccine against canine visceral leishmaniasis in Brazil.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Evaluation of immune responses and protection induced by A2 and nucleoside hydrolase (NH) DNA vaccines against Leishmania chagasi and Leishmania amazonensis experimental infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

The FML-vaccine (Leishmune) against canine visceral leishmaniasis: a transmission blocking vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Can spleen aspirations be safely used for the parasitological diagnosis of canine visceral leishmaniosis? A study on assymptomatic and polysymptomatic animals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

A cross-sectional serodiagnostic survey of canine leishmaniasis due to Leishmania chagasi.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Adverse vaccinal events in dogs and cats.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Humoral immunological profile and parasitological statuses of Leishmune vaccinated and visceral leishmaniasis infected dogs from an endemic area

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Value of two PCR methods for the diagnosis of canine visceral leishmaniasis and the detection of asymptomatic carriers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Epidemiology of canine leishmaniasis: prevalence, incidence and basic reproduction number calculated from a cross-sectional serological survey on the island of Gozo, Malta

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Transmission potential, skin inflammatory response, and parasitism of symptomatic and asymptomatic dogs with visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Temporal IgG subclasses response in dogs following vaccination against Leishmania with Leishmune®

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

The fucose-mannose ligand-ELISA in the diagnosis and prognosis of canine visceral leishmaniasis in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Longitudinal analysis of serological tests officially adopted by the Brazilian Ministry of Health for the diagnosis of canine visceral leishmaniasis in dogs vaccinated with Leishmune®

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

IgG subclass responses in a longitudinal study of canine visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Canine visceral leishmaniasis: relationships between clinical status, humoral immune response, haematology and Lutzomyia (Lutzomyia) longipalpis infectivity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Clinical, parasitologic, and immunologic evolution in dogs experimentally infected with sand fly-derived Leishmania chagasi promastigotes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Immunologic indicators of clinical progression during canine Leishmania infantum infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Comparison of monoclonal and polyclonal antibodies for the detection of canine IgG1 and IgG2, and associations with infection outcome in Leishmania infantum naturally infected dogs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Post mortem parasitological evaluation of dogs seroreactive for Leishmania from Rio de Janeiro, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Infectivity of seropositive dogs, showing different clinical forms of leishmaniasis, to Lutzomyia longipalpis phlebotomine sand flies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Diagnosis of canine leishmaniasis: conventional and molecular techniques using different tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Canine leishmaniasis: identification of asymptomatic carriers by polymerase chain reaction and immunoblotting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Isotype patterns of immunoglobulins: hallmarks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Relationship of Leishmania-specific IgG levels and IgG avidity with parasite density and clinical signs in canine leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Clinical value of anti-Leishmania (Leishmania) chagasi IgG titers detected by flow cytometry to distinguish infected from vaccinated dogs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

Comparison between splenic and lymph node aspirations as sampling methods for the parasitological detection of Leishmania chagasi infection in dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.046

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2013.12.046

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34658787&oldid=1975736065"